Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of ixazomib plus lenalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
jRCT2080222296Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in multiple myeloma (MM) comparing Ixazomib + lenalidomide + dexamethasone with Placebo + lenalidomide + dexamethasone (2 arms). Started Nov 2013; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on jRCT2080222296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222296.